Abstract
Due to the steadily rising morbidity and mortality, thyroid cancer remains the most commonly seen endocrine cancer. The present study attempted to investigate the mechanism from the perspective of long non-coding RNA (lncRNA) regulation. We identified 53 markedly increased lncRNAs in thyroid cancer samples according to TCGA data. Among them, high lncRNA DIO3OS expression was a risk factor for thyroid cancer patients’ poorer overall survival. DIO3OS showed to be considerably increased within thyroid cancer tissue samples and cells. Knocking down DIO3OS within thyroid carcinoma cells suppressed cancer cell viability, the capacity of DNA synthesis, cell invasion, as well as cell migration; besides, proliferating markers, ki-67 and PCNA, were decreased by DIO3OS knockdown. Cancer bioinformatics analysis suggested that NF-κB2 might be related to DIO3OS function in thyroid cancer carcinogenesis. NF-κB2 was positively correlated with DIO3OS, and DIO3OS knockdown decreased NF-κB2 protein levels. Knocking down NF-κB2 within thyroid carcinoma cells suppressed cancer cell viability, the capacity of DNA synthesis, cell invasion, cell migration, and the protein levels of proliferating markers. Let-7d directly targeted DIO3OS and NF-κB2; DIO3OS knockdown upregulated let-7d expression. The overexpression of let-7d suppressed cancer cell viability, the capacity of DNA synthesis, cell invasion, cell migration, as well as the protein levels of proliferating markers. Let-7d inhibition remarkably attenuated the functions of DIO3OS knockdown in NF-κB2 expression and thyroid cancer cell phenotype. In conclusion, DIO3OS/let-7d/NF-κB2 axis regulates the viability, DNA synthesis capacity, invasion, and migration of thyroid cancer cells. The clinical application of this axis needs further in vivo and clinical investigation.
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12079-020-00589-w/MediaObjects/12079_2020_589_Fig1_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12079-020-00589-w/MediaObjects/12079_2020_589_Fig2_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12079-020-00589-w/MediaObjects/12079_2020_589_Fig3_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12079-020-00589-w/MediaObjects/12079_2020_589_Fig4_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12079-020-00589-w/MediaObjects/12079_2020_589_Fig5_HTML.png)
![](http://media.springernature.com/m312/springer-static/image/art%3A10.1007%2Fs12079-020-00589-w/MediaObjects/12079_2020_589_Fig6_HTML.png)
Similar content being viewed by others
Data availability
Please contact the authors for data requests.
References
Chang L, Guo R, Yuan Z, Shi H, Zhang D (2018) LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging miR-206 in ovarian cancer. Cell Physiol Biochem 49:1289–1303. https://doi.org/10.1159/000493408
Cui K, ** S, Du Y, Yu J, Ma W (2019) Long noncoding RNA DIO3OS interacts with miR-122 to promote proliferation and invasion of pancreatic cancer cells through upregulating ALDOA. Cancer Cell Int 19
Djebali S et al (2012) Landscape of transcription in human cells. Nature 489:101–108. https://doi.org/10.1038/nature11233
Du Y, **a W, Zhang J, Wan D, Yang Z, Li X (2017) Comprehensive analysis of long noncoding RNA-mRNA co-expression patterns in thyroid cancer. Mol Biosyst 13:2107–2115. https://doi.org/10.1039/c7mb00375g
Elices MJ, Osborn L, Takada Y, Crouse C, Luhowskyj S, Hemler ME, Lobb RR (1990) VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 60:577–584. https://doi.org/10.1016/0092-8674(90)90661-w
Fusco A et al (1987) A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 328:170–172. https://doi.org/10.1038/328170a0
Gallel P et al (2008) Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma. Hum Pathol 39:994–1001. https://doi.org/10.1016/j.humpath.2007.11.015
Gao Y et al (2014) The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res 42:13799–13811. https://doi.org/10.1093/nar/gku1160
He RZ, Luo DX, Mo YY (2019) Emerging roles of lncRNAs in the post-transcriptional regulation in cancer. Genes Dis 6:6–15. https://doi.org/10.1016/j.gendis.2019.01.003
Hernandez A, Martinez ME, Croteau W, St Germain DL (2004) Complex organization and structure of sense and antisense transcripts expressed from the DIO3 gene imprinted locus. Genomics 83:413–424. https://doi.org/10.1016/j.ygeno.2003.08.024
Huang JL, Zheng L, Hu YW, Wang Q (2014) Characteristics of long non-coding RNA and its relation to hepatocellular carcinoma. Carcinogenesis 35:507–514. https://doi.org/10.1093/carcin/bgt405
Kaikkonen MU, Adelman K (2018) Emerging roles of non-coding RNA transcription. Trends Biochem Sci 43:654–667. https://doi.org/10.1016/j.tibs.2018.06.002
Kim SR et al (2008) Visfatin enhances ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB activation in endothelial cells. Biochim Biophys Acta 1783:886–895. https://doi.org/10.1016/j.bbamcr.2008.01.004
Li Y et al (2016) Integrated bioinformatics analysis of chromatin regulator EZH2 in regulating mRNA and lncRNA expression by ChIP sequencing and RNA sequencing. Oncotarget 7:81715–81726. https://doi.org/10.18632/oncotarget.13169
Li X et al (2018) Long non-coding RNA HOXD-AS1 promotes tumor progression and predicts poor prognosis in colorectal cancer. Int J Oncol 53:21–32. https://doi.org/10.3892/ijo.2018.4400
Lin YT et al (2019) Visfatin promotes monocyte adhesion by Upregulating ICAM-1 and VCAM-1 expression in endothelial cells via activation of p38-PI3K-Akt signaling and subsequent ROS production and IKK/NF-kappaB activation. Cell Physiol Biochem 52:1398–1411. https://doi.org/10.33594/000000098
Liu L, Yang J, Zhu X, Li D, Lv Z, Zhang X (2016) Long noncoding RNA H19 competitively binds miR-17-5p to regulate YES1 expression in thyroid cancer. FEBS J 283:2326–2339. https://doi.org/10.1111/febs.13741
Liu N, Zhou Q, Qi YH, Wang H, Yang L, Fan QY (2017a) Effects of long non-coding RNA H19 and microRNA let7a expression on thyroid cancer prognosis. Exp Mol Pathol 103:71–77. https://doi.org/10.1016/j.yexmp.2017.06.004
Liu S, **e F, **ang X, Liu S, Dong S, Qu K, Lin T (2017b) Identification of differentially expressed genes, lncRNAs and miRNAs which are associated with tumor malignant phenotypes in hepatoblastoma patients. Oncotarget 8:97554–97564. https://doi.org/10.18632/oncotarget.22181
Liu H, Deng H, Zhao Y, Li C, Liang Y (2018) LncRNA XIST/miR-34a axis modulates the cell proliferation and tumor growth of thyroid cancer through MET-PI3K-AKT signaling. J Exp Clin Cancer Res 37:279. https://doi.org/10.1186/s13046-018-0950-9
Liz J, Esteller M (2016) lncRNAs and microRNAs with a role in cancer development. Biochim Biophys Acta 1859:169–176. https://doi.org/10.1016/j.bbagrm.2015.06.015
Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z, Ai K (2014) H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour Biol 35:9163–9169. https://doi.org/10.1007/s13277-014-2185-5
Mou K, Liu B, Ding M, Mu X, Han D, Zhou Y, Wang LJ (2018) lncRNA-ATB functions as a competing endogenous RNA to promote YAP1 by sponging miR-590-5p in malignant melanoma. Int J Oncol 53:1094–1104. https://doi.org/10.3892/ijo.2018.4454
Murugan AK, Munirajan AK, Alzahrani AS (2018) Long noncoding RNAs: emerging players in thyroid cancer pathogenesis. Endocr Relat Cancer 25:R59–R82. https://doi.org/10.1530/ERC-17-0188
Na K, Li K, Sang T, Wu K, Wang Y, Wang X (2017) Anticarcinogenic effects of water extract of sporoderm-broken spores of Ganoderma lucidum on colorectal cancer in vitro and in vivo. Int J Oncol 50:1541–1554. https://doi.org/10.3892/ijo.2017.3939
Neely RJ et al (2011) The RET/PTC3 oncogene activates classical NF-kappaB by stabilizing NIK. Oncogene 30:87–96. https://doi.org/10.1038/onc.2010.396
Nikiforova MN, Chiosea SI, Nikiforov YE (2009) MicroRNA expression profiles in thyroid tumors. Endocr Pathol 20:85–91. https://doi.org/10.1007/s12022-009-9069-z
Ning YX, Luo X, Xu M, Feng X, Wang J (2017) Let-7d increases ovarian cancer cell sensitivity to a genistein analog by targeting c-Myc. Oncotarget 8:74836–74845. https://doi.org/10.18632/oncotarget.20413
Perdas E, Stawski R, Kaczka K, Zubrzycka M (2020) Analysis of Let-7 family miRNA in plasma as potential predictive biomarkers of diagnosis for papillary thyroid cancer. Diagnostics (Basel) 10. https://doi.org/10.3390/diagnostics10030130
Sakurai M, Miki Y, Masuda M, Hata S, Shibahara Y, Hirakawa H, Suzuki T, Sasano H (2012) LIN28: a regulator of tumor-suppressing activity of let-7 microRNA in human breast cancer. J Steroid Biochem Mol Biol 131:101–106. https://doi.org/10.1016/j.jsbmb.2011.10.007
Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP (2011) A ceRNA hypothesis: the Rosetta stone of a hidden RNA language? Cell 146:353–358. https://doi.org/10.1016/j.cell.2011.07.014
Sedaghati M, Kebebew E (2019) Long noncoding RNAs in thyroid cancer. Curr Opin Endocrinol Diabetes Obes 26:275–281. https://doi.org/10.1097/MED.0000000000000497
Shao T, Hu Y, Tang W, Shen H, Yu Z, Gu J (2019) The long noncoding RNA HOTAIR serves as a microRNA-34a-5p sponge to reduce nucleus pulposus cell apoptosis via a NOTCH1-mediated mechanism. Gene 715:144029. https://doi.org/10.1016/j.gene.2019.144029
Song Z, Zhao W, Cao D, Zhang J, Chen S (2018) Elementary screening of lymph node metastatic-related genes in gastric cancer based on the co-expression network of messenger RNA, microRNA and long non-coding RNA. Braz J Med Biol Res 51:e6685. https://doi.org/10.1590/1414-431x20176685
Sun T, Ye H, Wu CL, Lee GS, Kantoff PW (2014) Emerging players in prostate cancer: long non-coding RNAs. Am J Clin Exp Urol 2:294–299
Tan JY et al (2015) Extensive microRNA-mediated crosstalk between lncRNAs and mRNAs in mouse embryonic stem cells. Genome Res 25:655–666. https://doi.org/10.1101/gr.181974.114
Tang B, Bao N, He G, Wang J (2019) Long noncoding RNA HOTAIR regulates autophagy via the miR-20b-5p/ATG7 axis in hepatic ischemia/reperfusion injury. Gene 686:56–62. https://doi.org/10.1016/j.gene.2018.10.059
Wang KC, Chang HY (2011) Molecular mechanisms of long noncoding RNAs. Mol Cell 43:904–914. https://doi.org/10.1016/j.molcel.2011.08.018
Wei Y, Liu G, Wu B, Yuan Y, Pan Y (2018) Let-7d inhibits growth and metastasis in breast cancer by targeting Jab1/Cops5. Cell Physiol Biochem 47:2126–2135. https://doi.org/10.1159/000491523
Yang C, Li H, Zhang T, Chu Y, Chen D, Zuo J (2019) miR-200c overexpression inhibits the invasion and tumorigenicity of epithelial ovarian cancer cells by suppressing lncRNA HOTAIR in mice. J Cell Biochem. https://doi.org/10.1002/jcb.29387
Yoon JH, Abdelmohsen K, Gorospe M (2013) Posttranscriptional gene regulation by long noncoding RNA. J Mol Biol 425:3723–3730. https://doi.org/10.1016/j.jmb.2012.11.024
Zaballos MA, Santisteban P (2017) Key signaling pathways in thyroid cancer. J Endocrinol 235:R43–R61. https://doi.org/10.1530/JOE-17-0266235/2/R43
Zhang L et al (2013a) Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis 34:577–586. https://doi.org/10.1093/carcin/bgs381
Zhang X, Mao H, Lv Z (2013b) MicroRNA role in thyroid cancer pathogenesis. Front Biosci (Landmark Ed) 18:734–739. https://doi.org/10.2741/4135
Zhang H, Cai Y, Zheng L, Zhang Z, Lin X, Jiang N (2018) Long noncoding RNA NEAT1 regulate papillary thyroid cancer progression by modulating miR-129-5p/KLK7 expression. J Cell Physiol 233:6638–6648. https://doi.org/10.1002/jcp.26425
Zhao Y et al (2018) Construction and investigation of lncRNA-associated ceRNA regulatory network in papillary thyroid cancer. Oncol Rep 39:1197–1206. https://doi.org/10.3892/or.2018.6207
Zhou D, Li Z, Bai X (2017) BRAFV600E and RET/PTC promote proliferation and migration of papillary thyroid carcinoma cells in vitro by regulating nuclear factor-kappaB. Med Sci Monit 23:5321–5329. https://doi.org/10.12659/msm.904928
Zhu M et al (2014) lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J 281:3766–3775. https://doi.org/10.1111/febs.12902
Zhuang X et al (2019) Long noncoding RNA ABHD11-AS1 functions AS a competing endogenous RNA to regulate papillary thyroid cancer progression by miR-199a-5p/SLC1A5 axis. Cell Death Dis 10:620. https://doi.org/10.1038/s41419-019-1850-4
Funding
This work was supported by the Natural Science Foundation of Hunan Province, (2020JJ5835) and grants from the Innovation Project Fund of Hunan Development and Reform Commission (NO. 2019412).
Author information
Authors and Affiliations
Contributions
MW, JL, JH made substantial contribution to the conception and design of the work; ZZ, CR were involved in in the experimental conducting; TT, CL analyzed and interpreted the data; MW, YG drafted the manuscript; FY, ZW revised the work critically for important intellectual content; JH collected grants; Final approval of the work: all authors.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approvals
All procedures performed in studies involving human participants were in accordance with the Ethics Committee of the Second **angya Hospital and with the 1964 Helsinki declaration. Informed consent to participate in the study has been obtained from participants.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wang, M., Li, J., Zuo, Z. et al. Long non-coding RNA DIO3OS/let-7d/NF-κB2 axis regulates cells proliferation and metastasis of thyroid cancer cells. J. Cell Commun. Signal. 15, 237–250 (2021). https://doi.org/10.1007/s12079-020-00589-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12079-020-00589-w